News Focus
News Focus
icon url

NY1972

05/21/26 10:47 PM

#978 RE: jondoeuk #977

Many bios including ones in China can make ipsc NK. I don't see much value there. I think it is the CAR they are interested in, Dana-Farber Cancer Institute holds the mica/b trunk patent.
icon url

NY1972

05/21/26 11:04 PM

#979 RE: jondoeuk #977

They shut down the FT536 trial on ovarian cancer. The GBM trial is to see the impact of mica/b CAR on CNS lesions and safety.
icon url

NY1972

05/22/26 12:47 PM

#980 RE: jondoeuk #977

For the OV trial just canceled, pts must have received prior bevacizumab. They want an intact BBB in GBM pts to see the impact of CAR mica/b only